Novanta CFO Sold 3,000 shares

Novanta Inc (NASDAQ: NOVT) recently experienced a noteworthy insider transaction. Specifically, the company’s Chief Financial Officer, Robert Buckley, divested 3,000 shares on December 6, 2023.

Robert Buckley serves as the Chief Financial Officer at Novanta Inc., contributing substantial expertise in financial management and strategic planning to the company. His responsibilities encompass overseeing financial operations, aligning the company’s financial strategy with growth objectives, and effectively communicating financial performance to stakeholders.

Novanta Inc. operates globally, specializing in designing, developing, and manufacturing pivotal photonic and motion control components and subsystems. These innovative solutions play a critical role in advanced industrial and healthcare applications, where precision and reliability are paramount. Novanta’s product portfolio is integral to various equipment types, including medical devices, microelectronics, and industrial automation.

Examining Novanta Inc.’s insider transaction history reveals a notable absence of insider purchases over the past year, accompanied by ten recorded instances of insider sales within the same period.

Have you read?
Report: Vanuatu Citizenship by Investment Programme, 2023.
Report: CEO approval rating index, 2023.
PR for CEOs is Critical for Brand Success: Top PR Firms for CEOs.
Report: Top CEOs With The Highest Average Yearly Bonus, 2023.
Report: Top 20 worst countries for internet freedom, 2023.
Ranked: World’s Most Globalized Cities, 2023.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name